UMMC Navigation

Stroke

Main Content

MaRISS

Study title

Mild and rapidly improving stroke symptoms research study (MaRISS)

  • Principal Investigator: Dr. Rebecca Sugg

Purpose

This study aims to determine long-term outcomes of patients with mild and rapidly improving stroke and examine the association with tissue plasminogen activator (TPA) treatment.

Who can participate

Those eligible to participate in this study include:

  • Those who have experienced a mild ischemic stroke or rapidly improving stroke symptoms.

For more information

  • Susan Hetzel
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 984-5518
  • IRB Number: 2017-0207